Topic Archives: Merrill Lynch

Comments

  • Avatar

    I cannot buy either one of these--CTEQF or ECSIF--through my broker, Merrill Lynch, because there is not enough research...

  • Avatar

    Watch: ASX:ALL Major player in gaming industry world wide. Recently partnered up with BYD. My online brokeradge accou...

  • Avatar

    If you have not done so go to a local Fidelity, Schwab, Merrill Lynch, Morgan Stanley or UBS PLEASE visit them first. ...

  • Gr8Full!

    $GE reduced to 1/4 position, shall most likely use this name to further learn options trading in 2018... http://www....

  • Avatar

    $Biotech $IBB $XBI A new report issued by BoA/Merrill Lynch says biotech is the best place to be in the stock market...

  • Avatar

    Ivanhoe Mines Bank of America Merrill Lynch Conference Presentation by RF. https://www.ivanhoemines.com/site/assets/f...

  • Avatar

    Long the 4 As. Good article from Bloomberg. Stephen Gandel May 12, 2017 9:56 AM EDT The stock market, it appears, ...

  • Avatar

    After less than four months, performance not encouraging. Of nine stocks acted upon, one is profitable, three are flat ...

  • SoGiAm

    $HALO - Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2016 Global Health Care Conference http:/...

  • Avatar

    Alan, I think it is standard practice as Travis states that the brokerage house will ask your permission to loan your ...

  • SoGiAm

    $CELG long- tipranks.com Analyst Ying Huang from Merrill Lynch reiterated a Buy rating on Celgene (CELG), with a $125 p...

  • sogiam

    Roadshow: American Renal Associates Holdings, Inc. (IPO) http://retailroadshow.com/sys/launch.asp?qv=3979734794966461&k...

  • sogiam

    Roadshow: Hutchison China MediTech Limited (IPO) 3/8/2016 - 3/16/2016 Lead Underwriters: BofA Merrill Lynch, Deutsche...

  • Avatar

    We are in a perma bear market... iI use a complex chart to determine if a market crash is immenient. It's called the H...

  • sogiam

    CLLS-4 HN and Cellectis investors: Cellectis Announces Presentations at Upcoming Conferences New York, September 9, ...

  • sogiam

    GILD- Shares of Gilead rally on $10 billion bond pricing Today 12:03 PM ET (MarketWatch) Share Print Shares of Gilea...

  • Avatar

    Back after a brief hiatus and catching up on updates of those I hold: KPTI, TRIL, JUNO, BLCM, etc. DR.KSS a recent May ...

  • sogiam

    KPTI-Bank of America Merrill Lynch 2015 Healthcare Conference May 13, 2015 10:40 AM PT Webcast shall be available he...

  • Avatar

    $ESPR ESPR presentation at Bank of America Merrill Lynch 2015 Healthcare Conference starts in 45 minutes. No indicat...

  • ans_chandra

    $MEIP and $AKAO May 12: Achaogen to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May13:...

  • sogiam

    CLLS-(CMVLF) Cellectis-BANK OF AMERICA MERRILL LYNCH 2015 GLOBAL HEALTH CARE CONFERENCE April 12, 2015 to April 14, 2015...

  • Avatar

    Just a tip for you online investors. I use Merrill Lynch and because of my accounts with Bank of America I get 30 free ...

  • Avatar

    RE: $MEIP "Merrill Lynch initiates coverage for MEI PHARMA INC with BUY recommendation. BY Investars Analyst Actions...

  • Subramania

    Ok here we go for data from $ESPR. Already set a new high today! Esperion Therapeutics to Present at Bank of America ...

  • Avatar

    Useful links: Understanding Analysts’ Recommendations. FINRA’s guide provides some great information about how to ...

  • Avatar

    It seems that the lawyers are at it again. This time against DRTX. Their claim is: "The complaint seeks relief on beha...

  • Avatar

    Don't recall this company being discussed, but given its focus I wonder if Dr. KSS has an opinion on its approach. Rated...

  • Avatar

    One thing I learned from the DRTX call and the transcript clarified for me is that part of their strategy also is to gai...

  • Avatar

    I was able to buy BIOZF through Merrill Lynch with no problem. Dave...

  • Avatar

    Joe, I got off the phone with Merrill Lynch and they said the conversion rate was 5 to 1 and there would be no fee to co...

  • Avatar

    Walter- I have to admit that quite frankly I am lost following the technical charting. I have a very close friend that ...

  • Avatar

    Travis, I am feeling good that you too have had your interest raised by discussions. I have found the discussions recent...

  • Avatar

    Oz stocks ending with the letter F are trading in the USA; the F stands for foreign. They should be purchasable in a nor...

  • Avatar

    Siva, I greatly appreciate all the informative postings you have provided on this thread, and I would like to assist yo...

  • Avatar

    Where do we learn these concepts? Then make intelligent choices? For example, Merrill Lynch?...

  • Avatar

    Ron is correct. The legal issues are somewhat complicated because the broker was technically not making a "recommendati...

  • Avatar

    I enjoyed the story, and feel Jim not only acted accordingly to his clients wishes, but also tried to warn him of the po...

  • Jim Skelton,

    The firm was Merrill Lynch. I don't know why they approved/allowed the transactions, but they were done with the full kn...

  • Avatar

    I had Arsenal for a few months last year. Went through the reverse split and did not like the way the company handled i...

  • Avatar

    My turkey was a granddaddy although it didn't happen last year, but for me this is like confession. I was in college an...

  • Jim Skelton

    A bit of perspective on todays pricing of SBOTF. Imagine that you had embarked on a cruise two weeks ago. It was an "unp...

  • Jim Skelton

    It's 11:25 AM. Still waiting on news release that I figure will be pretty big one way or another. A company does not req...

  • Avatar

    I've been pleased with Merrill Lynch for stocks and ETFs - I keep some cash in BofA and a linked investment account with...

  • Avatar

    During the 70s, we had a Merrill Lynch broker who did NOT focus on commission; he actually considered his clients’ int...

  • Avatar

    Merrill Lynch put out an analysis on 20 Feb 2013 that gave a target price of $20 for GOV -- it is now at $24.68 as of cl...

  • Avatar

    I especially remember the Sep crash in 1987 or for that matter anyother crash or microcrash. Merrill Lynch office in Fl...

  • Avatar

    I have a test case going with merrill Lynch as to foreign tax witholding on this stock. ...

  • Avatar

    UTX may be working with Raser via their new division, but according to what I read, the equipment used for the geotherma...

  • Avatar

    I have subscribed to Blue Chip Growth for about three years, probably will not renew. Recommended stocks that I purchase...

  • Avatar

    October 23, 2008 Dear S&A Digest Reader, As you've probably heard by now – one of our associates recently c...

  • Avatar

    I hate Merrill Lynch - how they came to be so highly regarded is a mystery to me. Their Focus 1 stocks can't even beat C...

  • Avatar

    Great comments folks, thanks -- and thanks for the details on Alex's "Gone Fishin'" Portfolio. I don't think Merrill Ly...

  • Avatar

    Well, thanks to this holding and my puts on the Russian index my portfolio hasn't gone completely underwater -- it's bee...

  • Avatar

    I didn't see the teaser on this company when it first came out. Right now at around .40 I think LNG Energy is a good buy...

  • Avatar

    I scoped this one out too, based on the reference (quoted below)to Joseph Hooper: ["As a former Merrill Lynch stockbrok...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch